Navigation Links
Exclusive Industry Panel for Medical Device Developers - "The Great Innovators: A Sit-Down Chat with Dr. Thomas Fogarty & Dean Kamen"
Date:5/11/2012

PHILADELPHIA, May 11, 2012 /PRNewswire/ --

 

This new Q&A session features industry leaders Dean Kamen  and Dr. Thomas Fogarty  offering their insights into the future of medical device development. Free for attendees at MD&M East Philadelphia on May 23.

On Wednesday, May 23 at 2:30pm, Medical Design & Manufacturing East (MD&M East) will present the special panel, "The Great Innovators: A Sit-Down Chat with Dr. Thomas Fogarty & Dean Kamen." Led by UBM Canon's Director of Content, Rich Nass, this live Q&A panel will feature renowned inventor Dean Kamen, and MDEA Lifetime Achievement Award winner Dr. Thomas Fogarty.

Mr. Kamen and Dr. Fogarty are two of the most important and innovative minds in the medical device industry today.  Attendees will have the rare opportunity to interact directly with Mr. Kamen and Dr. Fogarty as they answer questions and share their insights into the future of medical device development and technology. This panel is free to all Expo attendees. Complete details and registration information are available at MDMEast.com.

About Dean Kamen

Dean Kamen is an inventor, entrepreneur, and advocate for science and technology. He has more than 440 U.S. and foreign patents and invented the first wearable infusion pump and the first wearable insulin pump for diabetes. Some of the many devices Mr. Kamen has worked on include the HomeChoice™ peritoneal dialysis system, Hydroflex™ surgical irrigation pump, the Crown™ stent, iBOT™ mobility device, and the Segway® Human Transporter. Mr. Kamen was awarded the National Medal of Technology in 2000, the Lemelson-MIT Prize 2002, and has been inducted into the National Inventors Hall of Fame in 2005.

About Dr. Thomas Fogarty

Dr. Thomas Fogarty's vast accomplishments in the medical device industry include having founded or co-founded more than 33 medical companies. Fogarty holds 135 patents on surgical instruments, among them the Fogarty balloon embolectomy catheter which revolutionized vascular surgery, became the first minimally invasive surgical device, and is still commonly used. Before Fogarty invented the arterial embolectomy catheter, up to 50% of patients were dying or losing limbs during surgery to remove blood clots. Fogarty's inventions have saved the lives of millions of people.

About MD&M East Exposition

MD&M East Expo will run from Tuesday, May 22through Thursday, May 24 on the main floor of the Pennsylvania Convention Center. MD&M East provides medical device engineers, R&D, quality, regulatory, design, and manufacturing contact with hundreds of the industry's medical OEM contract service providers, suppliers and consultants. Developers can quickly evaluate and compare end-to-end manufacturing solutions in one single location. Every stage of the product development cycle is represented, from research and design through regulatory approval and end-product marketing. Exposition registration is complimentary to qualified members of the medtech community at http://www.MDMEast.com.

Event Details
MD&M East

Exposition: May 22-24, 2012

Conference: May 21-24, 2012

Pennsylvania Convention Center

1101 Arch Street

Philadelphia, PA 19107

*Special panel "The Great Innovators: A Sit-Down Chat with Dr. Thomas Fogarty & Dean Kamen" -  Wednesday, May 23, 2:30pm-3:30pm, Innovation Briefs Theater, Booth 589, MD&M East Exhibit Floor

http://www.MDMEast.com

Editorial Contact:

Nannette Nolan
Marketing Manager, Medical Events
UBM Canon
nannette.nolan@ubm.com 
+1-310-996-9468

 



'/>"/>
SOURCE UBM Canon
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Knee Pain? An Exclusive Study Engineers Cartilage to Match Patients Own Tissue
2. PARI Nebulizer & Compressor Used Exclusively in Inspires Phase 3 CF Trial
3. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
4. Stem Cell Sciences Announces the Creation of the Worlds First Authentic Rat Embryonic Stem Cells from its Exclusively Licensed Technology
5. CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
6. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
7. Transgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test
8. The Quigley Corporation Licenses Naturally Derived Compound For Scar Improvement; License Requires Payments Totaling $1.1 Million To The Quigley Corporation Over A Five Year Period For Exclusive Ownership
9. DSM Obtains Exclusive World-Wide License for Innovative Drug Delivery Technology
10. John Legend and Gap Join (PRODUCT)RED(TM) to Help Eliminate AIDS in Africa with Exclusive (RED)ZONE Seating at Madison Square Garden
11. Debiopharm Group and Mercury Therapeutics, Inc. Sign an Exclusive License Agreement for the Development and Commercialisation of Debio 0930
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... MARLTON, N.J. , April 28, 2016   ... solutions, today announced that leading IT market research and ... Player " in the IDC MarketScape: Worldwide Pharmaceutical Track ... March 2016).  The report provides an assessment of the ... pharmaceutical track and trace software market. Logo ...
(Date:4/27/2016)... 2016  Hologic, Inc. (Nasdaq: HOLX ... the fiscal second quarter ended March 26, 2016.  ... increased 41.2%, and non-GAAP diluted EPS of $0.47 ... on a reported basis, and 6.3% on a ... another good quarter, highlighted by 14.6% growth in ...
(Date:4/27/2016)... -- Elekta today announced that its leading-edge ... focal point of seven scientific presentations at ESTRO 35, ... & Oncology, taking place April 29 - May 3. ... and a high-field MRI scanner with sophisticated software that ... in real time. The MR-linac is designed to improve ...
Breaking Medicine Technology:
(Date:4/28/2016)... ... April 28, 2016 , ... The Aging in Motion ... established an ICD-10-CM code for sarcopenia, giving it recognition for separate reporting and data ... October 1, 2016. , Sarcopenia is defined as a combination of low muscle mass ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... affected by a health insurance co-operative bankruptcy to receive their prescription medications ... receive over 1,500 FDA-approved prescription medications from over 180 American pharmaceutical companies ...
(Date:4/28/2016)... (PRWEB) , ... April 28, 2016 , ... ... announced its latest offering, the Protocol Calendar Exchange , is officially open ... pre-built, pre-reviewed protocol calendars available for sites to download into their clinical trial ...
(Date:4/28/2016)... Vail, Colorado (PRWEB) , ... April 28, 2016 ... ... LaPrade, MD, PhD, Chief Medical Officer at the Steadman Philippon Research Institute ... Capitol Hill Day to raise awareness about the debilitating and costly musculoskeletal ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... intelligent business communication applications and infrastructure for telecommunication service providers is pleased ... at Bestel’s Communications Network. The ACONYX Number Portability solution fully meets ...
Breaking Medicine News(10 mins):